Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M14,499Revenue (TTM) $M16,576Net Margin (%)10.8Altman Z-Score0.9
Enterprise Value $M26,905EPS (TTM) $1.4Operating Margin %16.5Piotroski F-Score5
P/E(ttm)27.8Beneish M-Score-2.5Pre-tax Margin (%)14.3Higher ROA y-yN
Price/Book1.010-y EBITDA Growth Rate %24.5Quick Ratio0.6Cash flow > EarningsY
Price/Sales1.15-y EBITDA Growth Rate %22.1Current Ratio0.8Lower Leverage y-yY
Price/Free Cash Flow10.1y-y EBITDA Growth Rate %-60.6ROA % (ttm)4.4Higher Current Ratio y-yY
Dividend Yield %1.1PEG1.2ROE % (ttm)12.5Less Shares Outstanding y-yN
Payout Ratio %28.0Shares Outstanding M388ROIC % (ttm)7.5Gross Margin Increase y-yN

Gurus Latest Trades with MKGAY

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

MKGAY is held by these investors:



MKGAY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about MKGAY:

    News about MKGAY:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Merck KGaA Shares Spike After FDA Approves Skin Cancer Treatment Mar 24 2017
    Merck KGaA :MKGAY-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017 Mar 16 2017
    European Stock Markets Mixed on Thursday as London and Paris Slump Jan 26 2017
    Merck Acquires BioControl to Strengthen Position in Food Safety Testing Jan 04 2017
    ETFs with exposure to Merck KGaA : December 22, 2016 Dec 22 2016
    Metformin Products, including Glucophage® Approved for Type 2 Diabetes Patients with Moderate Renal... Dec 21 2016
    Merck and the European Space Agency Extend Collaboration to Foster Innovation, Digitalization Dec 16 2016
    Frosty-brilliant Silver Shine: The Merck Pigment Innovation Ronastar® Frozen Jewel Nov 22 2016
    Merck KGaA :MKGAY-US: Earnings Analysis: Q3, 2016 By the Numbers : November 17, 2016 Nov 17 2016
    Merck Raises Profit Forecast for 2016 Following Good Third Quarter Nov 16 2016
    Germany's Merck Lifts Full-Year Guidance After Sigma-Aldrich Boosts Sales Nov 15 2016
    Merck KGaA, Darmstadt, Germany's Phase IIb ADDRESS II Results Confirm Potential of Atacicept as a... Nov 14 2016
    European Stock Markets Rally After Early Morning Bloodbath, Trump Concerns Ease Nov 09 2016
    Merck Invests € 250 Million in Production Value Chain in China Nov 07 2016
    Merck KGaA, Darmstadt, Germany, Presents Phase II Data on the Safety and Efficacy of Atacicept at... Nov 02 2016
    Merck KGaA, Darmstadt, Germany, Presents Phase II Data on the Safety and Efficacy of Atacicept at... Nov 02 2016
    Merck KGaA, Darmstadt, Germany Partners with American Cancer Society to Address Cancer in Women Nov 01 2016
    European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the... Oct 31 2016
    European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the... Oct 31 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)